Clinical Trial: Improving Management of Patients at High Risk for Osteoporotic Fractures

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck
ClinicalTrials.gov Identifier: NCT00139438

Purpose

The purpose of this study is to assess the impact of disease management interventions on percent receiving a bone densitometry test, percent appropriately prescribed a medication for osteoporosis, and compliance (% of those prescribed osteoporosis medications that continue with them for at least 6 months) among at risk patients.
Condition Intervention
Osteoporosis
 Behavior: Disease Management Assessment

MedlinePlus related topics:  Osteoporosis

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Dose Comparison, Parallel Assignment

Further Study Details: 
Primary Outcomes: Bone mineral density (BMD) testing rates
Secondary Outcomes: Osteoporosis medication treatment rates and medication
Expected Total Enrollment:  9369

Study start: September 2004

Eligibility

Ages Eligible for Study:  45 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

  • Members of the Horizon Blue Cross who are at risk for osteoporosis based on age (women age 65 or older, men and women age 45 or older who have a history of fragility fracture or have a history of taking oral glucocorticoids over 3 months).

Exclusion Criteria:

  • Individuals who are not members of Horizon Blue and who otherwise do not meet the inclusion criteria.

Location Information

Study chairs or principal investigators

Medical Monitor,  Study Director,  Merck   

More Information

Study ID Numbers:  2005_049
Last Updated:  September 7, 2005
Record first received:  August 29, 2005
ClinicalTrials.gov Identifier:  NCT00139438
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13



Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us